CVSACovista Inc.

$137.84

Price

$137.84+16%1Y
1M+20%1Y+16%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Average
6/10
Value35
Quality82
Momentum55
Growth53
Strongest Quality, weakest Value · ranked vs Consumer Defensive peers. The five questions below judge the company on its own terms.
What they do

Adtalem is the leading healthcare educator in the U.S. and a systemically important solution for preparing a diverse talent workforce that meets the needs of the healthcare industry. The purpose of Adtalem is to empower students to achieve their goals, find success, and make inspiring contributions to our global community. Adtalem is comprised of five like-kind institutions, with programs focusing on healthcare, including nursing, social and behavioral sciences, medicine, veterinary medicine, and more.

In the company’s own words · 10-K filed Aug 7, 2025 · SEC EDGAR

P/E (TTM)21.5
Market Cap$4.05B
1Y Return+16%
5Y Return+276%

Business segments

Q1 2026 · $484.6M

The company’s own SEC segment disclosure.

  • Chamberlain University$197.0M41%
  • Walden University$186.6M39%
  • Medical And Veterinary$101.1M21%

Covista Inc. (CVSA) reported revenue of $487M in Q3 2026 (quarter ended March 31, 2026), up 4.5% from the same quarter a year earlier. That came with a gross margin of 57% and net income of $42M (8.5% of revenue). For the full year FY2025, revenue was $1.79B (+13% year on year) and net income $237M. Its largest segment in 2026-Q1 was Chamberlain University at $197M, 41% of the disclosed total, just ahead of Walden University at 39%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.